SHPHF.US Sihuan Pharmaceutical Holdings Group Ltd

Healthcare Pharmaceuticals USA Stocks
0.2103 USD
Close of Nov 18, 2026
0.1200 0.2103
Market cap
USD 1.92B
P/E
-
P/B
1.19x
ROE
14.6%
Dividend yield
2.32%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is SHPHF.US undervalued?

Graham number

The Graham number of Sihuan Pharmaceutical Holdings Group Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sihuan Pharmaceutical Holdings Group Ltd fundamental analysis

No fundamental analysis for Sihuan Pharmaceutical Holdings Group Ltd yet.

Sihuan Pharmaceutical Holdings Group Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sihuan Pharmaceutical Holdings Group Ltd

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculptu…

Full company profile